advisorsecurities master

RANIRani Therapeutics Holdings, Inc. Class A Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key
20782
Ticker
RANI
Type
CSCommon Stock
Exchange
Nasdaq(XNAS)
Venue group
NASDAQ
Operating MIC
XNAS
Market
stocks
Locale
us
Currency
USD
Listed
2021-07-30
Round lot
100
Active
Yes
Last seen in a load
2026-08-14 20:49
Vendor updated
2026-08-13 06:09
Ticker root / suffix
RANI

Detail

Enriched 2026-08-14 20:47

Market cap
$90,226,011.23
Shares outstanding (class)
99,912,515
Shares outstanding (weighted)
112,389,152
SIC
2834 PHARMACEUTICAL PREPARATIONS
Employees
69
Location
SAN JOSE, CA
Description

Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.

Market cap and share counts drift.

Funds holding this security

Identifiers

Classification

Fund data